Barclays »

An2 Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $92k 28k 3.24
2023-12-31 $907k 44k 20.50
2023-09-30 $51k 3.2k 16.09
2023-06-30 $230k 27k 8.50
2023-03-31 $323k 33k 9.86
2022-12-31 $286k 30k 9.51
2022-09-30 $475k 27k 17.41
2022-06-30 $38k 4.9k 7.77
2022-03-31 $275k 18k 15.09